Compounded GLP-1s: What They Are and How to Check a Supplier

In short

Compounded GLP-1 products are prepared by pharmacies rather than manufactured and approved. They are not FDA-approved medicines, they are not covered by.

By Alsen Walker · Updated October 6, 2026

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinician

Compounded GLP-1 products are prepared by pharmacies rather than manufactured and approved. They are not FDA-approved medicines, they are not covered by insurance, and the rules governing them have changed as shortage status changed. This cluster explains what they legally are, how to check a supplier, and where the real risks sit.

The fastest test of any supplier: ask which pharmacy or outsourcing facility prepares the product, by name. A legitimate operation answers immediately. Evasion, a brand name that is not a pharmacy, or a promise to follow up is your answer.

Regulatory status in this area changes. Verify the current position with FDA directly rather than relying on any article, including this one. Sellers have a commercial interest in the previous position.

What compounded means

A pharmacy preparing a medication for an individual patient rather than a manufacturer producing an approved product. Lawful within limits, and lacking the pre-market review of safety and efficacy that approval involves.

Compounding copies of approved drugs is restricted. A shortage designation is one route that opens it, which is why this market expanded during supply constraints and narrowed when they eased.

Where the real risks are

Not usually the molecule. The risks are concentration variation between pharmacies, dosing instructions given in insulin units with no reliable conversion, salt forms that are not the approved active ingredient, and for products bought outside pharmacies entirely, no assurance of identity, purity or sterility.

Tenfold dosing errors from unit confusion are documented, and poison centres have received calls arising from exactly this.

Research peptides are a different category

Products labelled for laboratory use and not for human consumption are not medicines. That labelling exists so the seller can operate outside drug regulation, and it is not a formality.

Checking a supplier

Verify the pharmacy with your state board of pharmacy, and check FDA’s registered outsourcing facility list if 503B status is claimed. Verify the prescriber with your state medical board.

If you cannot identify who prescribed your medication, you do not have a prescriber. You have a seller.

Coverage

Insurance does not cover compounded GLP-1s, and appeals do not change that, because there is no clinical decision to overturn. Effort is better spent getting an approved product covered.

If something goes wrong

Seek care and tell them exactly what you took and where it came from. Report to FDA MedWatch and your state board of pharmacy. Reports are how patterns get identified.

Every guide in this cluster

Sources and further reading

US Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. www.fda.gov
US Food and Drug Administration. BeSafeRx: Your source for online pharmacy information. www.fda.gov
MedlinePlus (US National Library of Medicine). Semaglutide injection: drug information. medlineplus.gov
MedlinePlus (US National Library of Medicine). Tirzepatide injection: drug information. medlineplus.gov
National Institute of Diabetes and Digestive and Kidney Diseases (NIH). Prescription medications to treat overweight and obesity. www.niddk.nih.gov

GLP1Hub content is for general information and is not medical advice. Prices and coverage rules change often, so confirm current details with the provider, your insurer and your prescriber. See our editorial standards and medical disclaimer.

Alsen Walker

Alsen Walker is a health writer and researcher at GLP1Hub with five years of experience researching and writing health and medical content. He works in a medical-field role alongside his undergraduate studies. At GLP1Hub he researches GLP-1 weight loss programs, pricing and insurance rules, and checks claims against FDA prescribing information, published clinical trials and official government sources. Alsen is not a physician, and his articles are general information, not medical advice.